Back to Search
Start Over
Reports Outline Melanoma Study Results from Public Assistance - Paris Hospitals (AP-HP) (Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial)
- Source :
- Obesity, Fitness & Wellness Week. December 5, 2020, 1540
- Publication Year :
- 2020
-
Abstract
- 2020 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Melanoma. According to news reporting [...]
Details
- Language :
- English
- ISSN :
- 15316386
- Database :
- Gale General OneFile
- Journal :
- Obesity, Fitness & Wellness Week
- Publication Type :
- Periodical
- Accession number :
- edsgcl.643167280